References
- Ross JA, Auger MJ, In Burke B, Lewis CE: The biology of the macrophage. In: Burke B, Lewis CE eds.: The macrophage. 2nd ed, p1-72, Oxford Medical Publications, Oxford, UK, 2002
- Nathan C: Inducible nitric oxide synthase: what difference does it make? J Clin Invest 100;2417-2423, 1997 https://doi.org/10.1172/JCI119782
- Bogdan C: Nitric oxide and the immune response. Nat Immunol 2; 907-916, 2001 https://doi.org/10.1038/ni1001-907
- Vila-Del Sol V, Fresno M: Involvement of TNF and NF-{kappa}B in the transcriptional control of cyclooxygenase-2 expression by IFN-{gamma} in macrophages. J Immunol 174; 2825-2833, 2005 https://doi.org/10.4049/jimmunol.174.5.2825
- Isomaki P, Punnonen J: Pro-and anti-inflammatory cytokines in rheumatoid arthritis. Ann Med 29;499-507, 1997 https://doi.org/10.3109/07853899709007474
- Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 105;1135-1143, 2000 https://doi.org/10.1161/hc0902.104353
- Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, Huber C: Serum levels of cytokines in chronic liver diseases. Gastroenterology 103;264-274, 1992 https://doi.org/10.1016/0016-5085(92)91122-K
- Coker RK, Laurent GJ: Pulmonary fibrosis: cytokines in the balance. Eur Respir J 11;1218-1221, 1998 https://doi.org/10.1183/09031936.98.11061218
- Chenevier-Gobeaux C, Morin-Robinet S, Lemarechal H, Poiraudeau S, Ekindjian JC, Borderie D: Effects of pro- and anti-inflammatory cytokines and nitric oxide donors on hyaluronic acid synthesis by synovial cells from patients with rheumatoid arthritis. Clin Sci 107;291-296, 2004 https://doi.org/10.1042/CS20040104
- Nishimoto N: Cytokine signal regulation and autoimmune disorders. Autoimmunity 38;359-367, 2005 https://doi.org/10.1080/08916930500124106
- Zhong B, Tajima M, Takahara H, Nochi H, Tamoto K, Tamura N, Kobayashi S, Tamura Y, Ikeda M, Akimoto T, Yoshino S, Hashimoto H: Inhibitory effect of mizoribine on matrix metalloproteinase-1 production in synovial fibroblasts and THP-1 macrophages. Mod Rheumatol 15;264-268, 2005 https://doi.org/10.1007/s10165-005-0406-x
- Feldmann M, Brennan FM, Maini RN: Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14;397-440, 1996 https://doi.org/10.1146/annurev.immunol.14.1.397
- Cush JJ, Lipsky PE: Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis. Arthritis Rheum 31;1230-1238, 1988 https://doi.org/10.1002/art.1780311003
- Janossy G, Panayi G, Duke O, Bofill M, Poulter LW, Goldstein G: Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation. Lancet 17;839-842, 1981 https://doi.org/10.1016/S0140-6736(02)98176-6
- Ishikawa H: Mizoribine and mycophenolate mofetil. Curr Med Chem 6;575-597, 1999
- Shunsei H, Tamiko Y: Inhibition of expression of cyclin A in human B cells by an immunosuppressant Mizoribine. J Immunol 155;5175-5183, 1995
- Stuehr DJ, Nathan CF: Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 169;1543-1555, 1989 https://doi.org/10.1084/jem.169.5.1543
- Majumder N, Dey R, Mathur RK, Datta S, Maitra M, Ghosh S, Saha B, Majumdar S. An unusual pro-inflammatory role of interleukin-10 induced by arabinosylated lipoarabinomannan in murine peritoneal macrophages. Glycoconj J 23;675-86, 2006 https://doi.org/10.1007/s10719-006-9017-9
- Yukoh A, Takako M, Shu-Ichi I, Shigenori K, Tomoyuki M, Masaaki M, Masaaki I, Toshihiro M, Shumpei Y: Mizoribine as an effective combined maintenance therapy with prednisolone in child-onset systemic lupus erythematosus. Pediatr Int 44;199-204, 2002 https://doi.org/10.1046/j.1328-8067.2001.01534.x
- Rieko N, Kazunari K, Yoshiyuki O, Yuichiro Y: Mizoribine treatment for childhood IgA nephropathy. Pediatr Int 44; 217-223, 2002 https://doi.org/10.1046/j.1328-8067.2001.01532.x
- Yoshifusa A, Yuichiro T, Masataka H, Masayuki N, Katsushi M, Shuichiro W, Yasuhei O, Yoji I: Pharmacokinetic study of mizoribine in an adolescent with lupus nephritis. Pediatr Int 46;597-600, 2004 https://doi.org/10.1111/j.1442-200x.2004.01936.x
- Imaizumi Y, Saura R, Mizuno K, Nakagami K: The antiproliferative effect of mizoribine on rheumatoid synovial fibroblast mediated by induction of apoptosis. Kobe J Med Sci 47;13-23, 2001
- Lee DM, Weinblatt ME: Rheumatoid arthritis. Lancet 358; 903-911, 2001 https://doi.org/10.1016/S0140-6736(01)06075-5
- Seitz M, Loetscher P, Dewald B, Towbin H, Ceska M, Baggiolini M: Production of interleukin-1 receptor antagonist, inflammatory chemotactic proteins, and prostaglandin E by rheumatoid and osteoarthritic synoviocytes-regulation by IFN-gamma and IL-4. J Immunol 152;2060-2065, 1994
- Taylor DJ: Interleukin-4 (IL-4) induces down-modulation and shedding of the p55 tumor necrosis factor receptor and inhibits TNF alpha's effect on rheumatoid synovial fibroblasts. Rheumatol Int 14;21-25, 1994 https://doi.org/10.1007/BF00302667
- Borghaei RC, Rawlings PL Jr, Mochan E: Interleukin-4 suppression of interleukin-1-induced transcription of collagenase (MMP-1) and stromelysin 1 (MMP-3) in human synovial fibroblasts. Arthritis Rheum 41;1398-1406, 1998 https://doi.org/10.1002/1529-0131(199808)41:8<1398::AID-ART8>3.0.CO;2-B
- Dechanet J, Briolay J, Rissoan MC, Chomarat P, Galizzi JP, Banchereau J, Miossec P: IL-4 inhibits growth factorstimulated rheumatoid synoviocyte proliferation by blocking the early phases of the cell cycle. J Immunol 151;4908-4917,1993
- Suzuki E, Umezawa K: Inhibition of macrophage activation and phagocytosis by a novel NF-kappaB inhibitor, dihydroxymethylepoxyquinomicin. Biomed Pharmacother 60;578-586, 2006 https://doi.org/10.1016/j.biopha.2006.07.089